摘要
目的探讨平阳霉素-活性炭纳米微粒(PYM-CH-NP)对人舌鳞癌细胞系Tca8113和颊鳞癌细胞系Bca-CD885的药物敏感性。方法采用甲基噻唑基四唑(MTT)法检测不同剂量的PYM-CH-NP和平阳霉素(PYM)在7个时间点(1~7d)对Tca8113和BcaCD885的杀伤效应,计算各时间点2种剂型的半数抑癌率浓度值(IC50)、抑癌率和药物抗肿瘤作用强度的相对值(RAA),选择药物作用后第5天观察量效关系。结果 PYM-CH-NP和PYM对Tca8113和BcaCD885均有较强的抑癌作用,其抗癌效应与药物浓度和作用时间相关。结论改型后的PYM-CH-NP保留了PYM的抗癌活性,且具有缓释性,作用于肿瘤时可以维持周围有效的浓度和作用时间,有效地杀伤肿瘤细胞。
Objective The cytotoxic effects of a new formulation of Pingyangmycin-activated carbon nanoparticles(PYM-CH-NP) on two human oral squamous cell carcinoma Tca8113 and BcaCD885 cell lines were studied in vitro. Methods The inhibitory effects of PYM-CH-NP and Pingyangmycin(PYM) were evaluated by methyl thiazolyl tetrazolium(MTT) assay at 1-7 days. The 50% inhibition concentration values(IC50) and relative anti tumor activity(RAA) of PYM-CH-NP and PYM against Tca8113 and BcaCD885 with different drug concentration were evaluated. The time-dependent cytotoxic effects of PYM-CH-NP and PYM were during 1-5 days, so the doseeffect relationship was investigated at 5th day. Results Both PYM-CH-NP and PYM had high anticancer effects on Tca8113 and BcaCD885, and the cytotoxic effects were dose-dependent and time-dependent. Conclusion The activated carbon nanoparticles(CH-NP) may serve as a new drug delivery carrier of PYM. The new formulation PYM-CH-NP could slow down drug release, prolonged the drug concentration and its acting time, so more effective anticancer efficacy could be achieved.
出处
《华西口腔医学杂志》
CAS
CSCD
北大核心
2010年第3期257-260,共4页
West China Journal of Stomatology
基金
卫生部科学研究基金资助项目(98-1-221)
关键词
活性炭
纳米微粒
平阳霉素
口腔肿瘤
缓释作用
activated carbon
nanoparticle
Pingyangmycin
oral cancer
sustained release